Home/Pipeline/Glaucoma Blood Flow Assessment

Glaucoma Blood Flow Assessment

Glaucoma

Research/Clinical ValidationActive

Key Facts

Indication

Glaucoma

Phase

Research/Clinical Validation

Status

Active

Company

Vasoptic Medical

About Vasoptic Medical

Vasoptic Medical is a privately-held developer of advanced blood flow imaging systems based on Laser Speckle Contrast Imaging (LSCI). Founded in 2014 and headquartered in Rochester, New York, the company targets the cardiovascular, diagnostics, and medical device sectors with its non-invasive, dye-free technology. Its primary products, the XyCAM and VasoVUE imagers, are positioned as complementary tools to existing angiography methods, offering dynamic flow data for research and clinical use in conditions like glaucoma, diabetic retinopathy, and systemic vascular diseases. The company is currently in an early commercial stage, engaging with the research community and beginning clinical adoption.

View full company profile

Therapeutic Areas

Glaucoma Diabetic Retinopathy Retinopathy of Prematurity Cardiovascular Diseases

Other Glaucoma Drugs

Drug	Company	Phase	Status
PREZIA Glaucoma Implant	PolyActiva	Preclinical	Active
MIGS Device System	Micropoint Biotechnologies	Commercial	Market approved in China
INM-088	InMed Pharmaceuticals	Preclinical	Active
OT-401	Ocumension Therapeutics	Phase 2	Active
ANX007	Annexon Biosciences	Phase 2	Active
PER-001	Perfuse Therapeutics	Phase 2	Active
hOTX2	BrainEver	Discovery	Active
Glaucoma Treatment	BVI Medical	Commercial	Active
MediPrint Lens (Glaucoma)	MediPrint Ophthalmics	Phase 2b	Active
Glaucoma Program	Broadwing Bio	Pre-clinical	Active
MSC Exosomal Eye Serum	Vitti Labs	Pre-clinical	Active
BTQ1902	Betaliq	Phase 2	Active